ECN Capital Corp.

DB:2EZ Stock Report

Market Cap: €533.2m

ECN Capital Valuation

Is 2EZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 2EZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 2EZ's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 2EZ's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 2EZ?

Key metric: As 2EZ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 2EZ. This is calculated by dividing 2EZ's market cap by their current revenue.
What is 2EZ's PS Ratio?
PS Ratio4.4x
SalesUS$129.61m
Market CapUS$563.31m

Price to Sales Ratio vs Peers

How does 2EZ's PS Ratio compare to its peers?

The above table shows the PS ratio for 2EZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.3x
GLJ Grenke
1.3x14.1%€698.9m
ALG ALBIS Leasing
1.6xn/a€58.1m
FRS FORIS
0.5xn/a€12.4m
PBB Deutsche Pfandbriefbank
1.8x12.0%€671.6m
2EZ ECN Capital
4.4x31.0%€790.0m

Price-To-Sales vs Peers: 2EZ is expensive based on its Price-To-Sales Ratio (4.4x) compared to the peer average (1.3x).

Price to Sales Ratio vs Industry

How does 2EZ's PS Ratio compare vs other companies in the DE Diversified Financial Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
EBEN aifinyo
0.3xn/aUS$15.51m
EBEN aifinyo
0.2xn/aUS$14.03m
CSQ creditshelf
0.005xn/aUS$29.25k
No more companies available in this PS range
2EZ 4.4xIndustry Avg. 2.0xNo. of Companies3PS01.22.43.64.86+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 2EZ is expensive based on its Price-To-Sales Ratio (4.4x) compared to the European Diversified Financial industry average (2x).

Price to Sales Ratio vs Fair Ratio

What is 2EZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

2EZ PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4.4x
Fair PS Ratio3.7x

Price-To-Sales vs Fair Ratio: 2EZ is expensive based on its Price-To-Sales Ratio (4.4x) compared to the estimated Fair Price-To-Sales Ratio (3.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 2EZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€1.85
€2.20
+18.7%
12.9%€2.53€1.69n/a5
Nov ’25€1.42
€1.63
+14.7%
11.4%€1.98€1.48n/a5
Oct ’25€1.42
€1.63
+14.7%
11.4%€1.98€1.48n/a5
Sep ’25€1.40
€1.63
+16.3%
11.4%€1.98€1.48n/a5
Aug ’25€1.38
€1.50
+9.0%
15.7%€2.01€1.34n/a6
Jul ’25€1.11
€1.47
+32.2%
15.9%€2.02€1.35n/a7
Jun ’25€1.14
€1.47
+28.7%
15.9%€2.02€1.35n/a7
May ’25€1.17
€1.59
+36.1%
23.2%€2.38€1.29n/a7
Apr ’25€1.36
€1.59
+17.1%
23.2%€2.38€1.29n/a7
Mar ’25€1.85
€1.99
+7.7%
10.6%€2.40€1.71n/a7
Feb ’25€1.84
€1.99
+8.3%
10.6%€2.40€1.71n/a7
Jan ’25€1.94
€1.84
-5.1%
11.8%€2.35€1.68n/a7
Dec ’24€1.48
€1.84
+24.4%
11.8%€2.35€1.68n/a7
Nov ’24€1.28
€2.01
+56.9%
19.2%€2.74€1.54€1.427
Oct ’24€1.59
€2.26
+42.2%
15.2%€2.82€1.94€1.426
Sep ’24€1.76
€2.21
+25.5%
14.0%€2.72€1.87€1.406
Aug ’24€1.70
€2.32
+36.3%
17.0%€3.09€1.89€1.386
Jul ’24€1.81
€2.43
+34.3%
16.5%€3.09€1.89€1.116
Jun ’24€1.96
€2.43
+24.0%
16.5%€3.09€1.89€1.146
May ’24€2.06
€2.79
+35.3%
16.5%€3.68€2.34€1.176
Apr ’24€1.78
€2.74
+53.7%
21.0%€3.72€1.86€1.366
Mar ’24€1.96
€3.24
+65.5%
11.1%€3.78€2.75€1.857
Feb ’24€1.97
€3.24
+64.7%
11.1%€3.78€2.75€1.847
Jan ’24€1.87
€3.73
+99.3%
10.4%€4.42€2.95€1.948
Dec ’23€2.16
€3.73
+72.6%
10.4%€4.42€2.95€1.488
Nov ’23€3.00
€5.55
+85.0%
7.3%€6.32€4.83€1.287

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Yeahka

HK$4.3b

An investment holding company, provides payment and business services to merchants and consumers in the People’s Republic of China.

4YE

HK$1.21

7D

-5.5%

1Y

-23.4%

Exor

€20.1b

Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.

EYX

€93.65

7D

-0.8%

1Y

7.7%

Merchants Bancorp

US$1.9b

Operates as the diversified bank holding company in the United States.

3KD

US$38.80

7D

7.8%

1Y

26.8%